Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' RINNE JO' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Anichtchik, OV; Peitsaro, N; Rinne, JO; Kalimo, H; Panula, P
      Distribution and modulation of histamine H-3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease

      NEUROBIOLOGY OF DISEASE
    2. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
      [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

      SYNAPSE
    3. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    4. Jaaskelainen, SK; Rinne, JO; Forssell, H; Tenovuo, O; Kaasinen, V; Sonninen, P; Bergman, J
      Role of the dopaminergic system in chronic pain - a fluorodopa-PET study

      PAIN
    5. Bruck, A; Portin, R; Lindell, A; Laihinen, A; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus

      NEUROSCIENCE LETTERS
    6. Lee, MS; Lyoo, CH; Ulmanen, I; Syvanen, AC; Rinne, JO
      Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease

      NEUROSCIENCE LETTERS
    7. Kemppainen, N; Marjamaki, P; Roytta, M; Rinne, JO
      Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing

      JOURNAL OF NEURAL TRANSMISSION
    8. Tuominen, S; Juvonen, V; Amberla, K; Jolma, T; Rinne, JO; Tuisku, S; Kurki, T; Marttila, R; Poyhonen, M; Savontaus, ML; Viitanen, M; Kalimo, H
      Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation

      STROKE
    9. Aberg, LE; Rinne, JO; Rajantie, I; Santavuori, P
      A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis

      NEUROLOGY
    10. Kaasinen, V; Nurmi, E; Bergman, J; Eskola, O; Solin, O; Sonninen, P; Rinne, JO
      Personality traits and brain dopaminergic function in Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Kaasinen, V; Nurmi, E; Bruck, A; Bergman, J; Solin, O; Rinne, JO
      Increased frontal [F-18]fluorodopa uptake in early Parkinson's Disease: sex differences in the prefrontal cortex

      BRAIN
    12. Kaasinen, V; Nagren, K; Hietala, J; Farde, L; Rinne, JO
      Sex differences in extrastriatal dopamine D-2-like receptors in the human brain

      AMERICAN JOURNAL OF PSYCHIATRY
    13. Mattila, PM; Roytta, M; Lonnberg, P; Marjamaki, P; Helenius, H; Rinne, JO
      Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment

      ACTA NEUROPATHOLOGICA
    14. Lee, MS; Rinne, JO; Marsden, CD
      The pedunculopontine nucleus: Its role in the genesis of movement disorders

      YONSEI MEDICAL JOURNAL
    15. Nurmi, E; Ruottinen, HM; Kaasinen, V; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT

      ANNALS OF NEUROLOGY
    16. Laihinen, A; Ruottinen, H; Rinne, JO; Haaparanta, M; Bergman, J; Solin, O; Koskenvuo, M; Marttila, R; Rinne, UK
      Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET

      JOURNAL OF NEUROLOGY
    17. Rinne, JO; Tommola, J; Laine, M; Krause, BJ; Schmidt, D; Kaasinen, V; Teras, M; Sipila, H; Sunnari, M
      The translating brain: cerebral activation patterns during simultaneous interpreting

      NEUROSCIENCE LETTERS
    18. Mattila, KM; Axelman, K; Rinne, JO; Blomberg, M; Lehtimaki, T; Laippala, P; Roytta, M; Viitanen, M; Wahlund, LO; Winblad, B; Lannfelt, L
      Interaction between estrogen receptor 1 and the epsilon 4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women

      NEUROSCIENCE LETTERS
    19. Nurmi, E; Bergman, J; Eskola, O; Solin, O; Hinkka, SM; Sonninen, P; Rinne, JO
      Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    20. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    21. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    22. Bhatia, KP; Lee, MS; Rinne, JO; Revesz, T; Scaravilli, F; Davies, L; Marsden, CD
      Corticobasal degeneration look-alikes

      CORTICOBASAL DEGENERATION AND RELATED DISORDERS
    23. Kemppainen, N; Ruottinen, H; Nagren, K; Rinne, JO
      PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD

      NEUROLOGY
    24. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
      Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

      NEUROLOGY
    25. Aberg, L; Liewendahl, K; Nikkinen, P; Autti, T; Rinne, JO; Santavuori, P
      Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms

      NEUROLOGY
    26. Verkkoniemi, A; Somer, M; Rinne, JO; Myllykangas, L; Crook, R; Hardy, J; Viitanen, M; Kalimo, H; Haltia, M
      Variant Alzheimer's disease with spastic paraparesis - Clinical characterization

      NEUROLOGY
    27. Ruottinen, HM; Partinen, M; Hublin, C; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

      NEUROLOGY
    28. Lamusuo, S; Pitkanen, A; Jutila, L; Ylinen, A; Partanen, K; Kalviainen, R; Ruottinen, HM; Oikonen, V; Nagren, K; Lehikoinen, P; Vapalahti, M; Vainio, P; Rinne, JO
      [C-11]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy - Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology

      NEUROLOGY
    29. Mattila, KM; Rinne, JO; Roytta, M; Laippala, P; Pietila, T; Kalimo, H; Koivula, T; Frey, H; Lehtimaki, T
      Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) geneinteractions with the apolipoprotein E epsilon 4 allele as risk factors inAlzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology

      JOURNAL OF MEDICAL GENETICS
    30. Anichtchik, OV; Rinne, JO; Kalimo, H; Panula, P
      An altered histaminergic innervation of the substantia nigra in Parkinson's disease

      EXPERIMENTAL NEUROLOGY
    31. Rinne, JO; Portin, R; Ruottinen, H; Nurmi, E; Bergman, J; Haaparanta, M; Solin, O
      Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study

      ARCHIVES OF NEUROLOGY
    32. Mattila, PM; Rinne, JO; Helenius, H; Dickson, DW; Roytta, M
      Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease

      ACTA NEUROPATHOLOGICA
    33. Rinne, JO; Bergman, J; Ruottinen, H; Haaparanta, M; Eronen, E; Oikonen, V; Sonninen, P; Solin, O
      Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease

      SYNAPSE
    34. Rinne, JO
      Drug development for neurodegenerative diseases: role of PET

      ANNALS OF MEDICINE
    35. Ma, SY; Roytta, M; Collan, Y; Rinne, JO
      Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    36. Kalimo, H; Viitanen, M; Amberla, K; Juvonen, V; Marttila, R; Poyhonen, M; Rinne, JO; Savontaus, ML; Tuisku, S; Winblad, B
      CADASIL: hereditary disease of arteries causing brain infarcts and dementia

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    37. Laine, M; Rinne, JO; Krause, BJ; Teras, M; Sipila, H
      Left hemisphere activation during processing of morphologically complex word forms in adults

      NEUROSCIENCE LETTERS
    38. Lee, MS; Kim, YD; Im, JH; Kim, HJ; Rinne, JO; Bhatia, KP
      I-123-IPT brain SPECT study in essential tremor and Parkinson's disease

      NEUROLOGY
    39. Rinne, JO; Ruottinen, H; Bergman, J; Haaparanta, M; Sonninen, P; Solin, O
      Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    40. Lamusuo, S; Forss, N; Ruottinen, HM; Bergman, J; Makela, JP; Mervaala, E; Solin, O; Rinne, JK; Ruotsalainen, U; Ylinen, A; Vapalahti, M; Hari, R; Rinne, JO
      [F-18]FDG-PET and whole-scalp MEG localization of epileptogenic cortex

      EPILEPSIA
    41. Kaisti, KK; Jaaskelainen, SK; Rinne, JO; Metsahonkala, L; Scheinin, H
      Epileptiform discharges during 2 MAC sevoflurane anesthesia in two healthyvolunteers

      ANESTHESIOLOGY
    42. Mattila, PM; Rinne, JO; Helenius, H; Roytta, M
      Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology

      ACTA NEUROPATHOLOGICA
    43. POHJALAINEN T; RINNE JO; NAGREN K; LEHIKOINEN P; ANTTILA K; SYVALAHTI EKG; HIETALA J
      THE A1 ALLELE OF THE HUMAN D-2 DOPAMINE-RECEPTOR GENE PREDICTS LOW D-2 RECEPTOR AVAILABILITY IN HEALTHY-VOLUNTEERS

      Molecular psychiatry
    44. REVONSUO A; PORTIN R; JUOTTONEN K; RINNE JO
      SEMANTIC PROCESSING OF SPOKEN WORDS IN ALZHEIMERS-DISEASE - AN ELECTROPHYSIOLOGICAL STUDY

      Journal of cognitive neuroscience
    45. SCHRAG A; RINNE JO; BURN DJ; MATHIAS CJ; MARSDEN CD; BROOKS DJ; QUINN NP
      OLIVOPONTOCEREBELLAR ATROPHY AND MULTIPLE SYSTEM ATROPHY - CLINICAL FOLLOW-UP OF 10 PATIENTS STUDIED WITH PET

      Annals of neurology
    46. Mattila, KM; Forsell, C; Pirttila, T; Rinne, JO; Lehtimaki, T; Roytta, M; Lilius, L; Eerola, A; St George-Hyslop, PH; Frey, H; Lannfelt, L
      The Glu318Gly mutation of the presenilin-1 gene does not necessarily causeAlzheimer's disease

      ANNALS OF NEUROLOGY
    47. Panula, P; Sallmen, T; Anichtchik, O; Kuokkanen, K; Lintunen, M; Rinne, JO; Matto, M; Kaslin, J; Eriksson, KS; Karlstedt, K
      Brain histamine in pathophysiological conditions and brain diseases

      HISTAMINE H3 RECEPTOR
    48. MA SY; ROYTTA M; COLLAN Y; RINNE JO
      UNBIASED MORPHOMETRICAL MEASUREMENTS SHOW NIGRAL NEURONAL LOSS WITH AGING

      Neurology
    49. RINNE JO; SAHLBERG N; RUOTTINEN H; NAGREN K; LEHIKOINEN P
      STRIATAL UPTAKE OF THE DOPAMINE REUPTAKE LIGAND [C-11] BETA-CFT IS REDUCED IN ALZHEIMERS-DISEASE ASSESSED BY POSITRON-EMISSION-TOMOGRAPHY

      Neurology
    50. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
      SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO

      The American journal of psychiatry
    51. MATTILA PM; KOSKELA T; ROYTTA M; LEHTIMAKI T; PIRTTILA TA; ILVESKOSKI E; KARHUNEN P; RINNE JO
      APOLIPOPROTEIN-E EPSILON-4 ALLELE FREQUENCY IS INCREASED IN PARKINSONS-DISEASE ONLY WITH COEXISTING ALZHEIMER PATHOLOGY

      Acta Neuropathologica
    52. MATTILA PM; ROYTTA M; TORIKKA H; DICKSON DW; RINNE JO
      CORTICAL LEWY BODIES AND ALZHEIMER-TYPE CHANGES IN PATIENTS WITH PARKINSONS-DISEASE

      Acta Neuropathologica
    53. LAINE M; VUORINEN E; RINNE JO
      PICTURE NAMING DEFICITS IN VASCULAR DEMENTIA AND ALZHEIMERS-DISEASE

      Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology
    54. RUOTTINEN HM; RINNE JO; OIKONEN VJ; BERGMAN JR; HAAPARANTA MT; SOLIN OH; RUOTSALAINEN UH; RINNE UK
      STRIATAL B-[F-18]FLUORODOPA ACCUMULATION AFTER COMBINED INHIBITION OFPERIPHERAL CATECHOL-O-METHYLTRANSFERASE AND MONOAMINE-OXIDASE TYPE-B - DIFFERING RESPONSE IN RELATION TO PRESYNAPTIC DOPAMINERGIC DYSFUNCTION

      Synapse
    55. RUOTTINEN HM; RINNE JO; BERGMAN JR; HAAPARANTA MT; SOLIN OH; OIKONEN VJ; RUOTSALAINEN UH; RINNE UK
      PROLONGED PET IMAGING DEMONSTRATES FURTHER INCREASE IN [F-18] FLUORODOPA (FDOPA) ACCUMULATION AFTER ENTACAPONE ADMINISTRATION

      Neurology
    56. MA SY; ROYTTA M; RINNE JO; COLLAN Y; RINNE UK
      CORRELATION BETWEEN NEUROMORPHOMETRY IN THE SUBSTANTIA-NIGRA AND CLINICAL-FEATURES IN PARKINSONS-DISEASE USING DISECTOR COUNTS

      Journal of the neurological sciences
    57. LAMUSUO S; RUOTTINEN HM; KNUUTI J; HARKONEN R; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; MERVAALA E; NOUSIAINEN U; JAASKELAINEN S; YLINEN A; KALVIAINEN R; RINNE JK; VAPALAHTI M; RINNE JO
      COMPARISON OF [F-18] FDG-PET, [TC-99M]-HMPAO-SPECT, AND [I-123] IOMAZENIL-SPECT IN LOCALIZING THE EPILEPTOGENIC CORTEX

      Journal of Neurology, Neurosurgery and Psychiatry
    58. RUOTTINEN HM; RINNE JO; HAAPARANTA M; SOLIN O; BERGMAN J; OIKONEN VJ; JARVELA I; SANTAVUORI P
      [F-18] FLUORODOPA PET SHOWS STRIATAL DOPAMINERGIC DYSFUNCTION IN JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    59. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI EKG; PELTONEN L; HIETALA J
      HUMAN D-2 DOPAMINE-RECEPTOR GENE POLYMORPHISMS AND BINDING CHARACTERISTICS IN-VIVO

      American journal of human genetics
    60. RINNE JO; HUBLIN C; PARTINEN M; RUOTTINEN H; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; LAIHINEN A
      STRIATAL DOPAMINE D-1 RECEPTORS IN NARCOLEPSY - A PET STUDY WITH [C-11]NNC-756

      Journal of sleep research
    61. KOIVISTO M; PORTIN R; RINNE JO
      PERCEPTUAL PRIMING IN ALZHEIMERS AND PARKINSONS DISEASES

      Neuropsychologia
    62. MA SY; RINNE JO; COLLAN Y; ROYTTA M; RINNE UK
      A QUANTITATIVE MORPHOMETRICAL STUDY OF NEURON DEGENERATION IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE

      Journal of the neurological sciences
    63. RINNE JO; LAIHINEN A; NAGREN K; RUOTTINEN H; RUOTSALAINEN U; RINNE UK
      PET EXAMINATION OF THE MONOAMINE TRANSPORTER WITH [C-11] BETA-CIT AND[C-11] BETA-CFT IN EARLY PARKINSONS-DISEASE

      Synapse
    64. RINNE JO; BURN DJ; MATHIAS CJ; QUINN NP; MARSDEN CD; BROOKS DJ
      OLIVOPONTOCEREBELLAR ATROPHY - REPLY

      Annals of neurology
    65. RINNE JO; BURN DJ; MATHIAS CJ; QUINN NP; MARSDEN CD; BROOKS DJ
      POSITRON EMISSION TOMOGRAPHY STUDIES ON THE DOPAMINERGIC SYSTEM AND STRIATAL OPIOID BINDING IN THE OLIVOPONTOCEREBELLAR ATROPHY VARIANT OF MULTIPLE SYSTEM ATROPHY

      Annals of neurology
    66. MA SY; ROYTTA M; RINNE JO; COLLEN Y; RINNE UK
      SINGLE SECTION AND DISECTOR COUNTS IN EVALUATING NEURONAL LOSS FROM THE SUBSTANTIA-NIGRA IN PATIENTS WITH PARKINSONS-DISEASE

      Neuropathology and applied neurobiology
    67. MA SY; COLLAN Y; ROYTTA M; RINNE JO; RINNE UK
      CELL COUNTS IN THE SUBSTANTIA-NIGRA - A COMPARISON OF SINGLE SECTION COUNTS AND DISECTOR COUNTS IN PATIENTS WITH PARKINSONS-DISEASE AND IN CONTROLS

      Neuropathology and applied neurobiology
    68. HILAKIVI I; AHTEE L; RINNE JO; TAIRA T; ATTILA LMJ; MARJAMAKI P
      EFFECTS OF MONOAMINE UPTAKE INHIBITORS GIVEN EARLY POSTNATALLY ON MONOAMINES IN THE BRAIN-STEM, CAUDATE PUTAMEN AND CORTEX, AND ON DOPAMINED-1 AND D-2 RECEPTORS IN THE CAUDATE/PUTAMEN/

      Journal of neural transmission
    69. RUOTTINEN HM; RINNE JO; RUOTSALAINEN UH; BERGMAN JR; OIKONEN VJ; HAAPARANTA MT; SOLIN OH; LAIHINEN AO; RINNE UK
      STRIATAL [F-18] FLUORODOPA UTILIZATION AFTER COMT INHIBITION WITH ENTACAPONE STUDIED WITH PET IN ADVANCED PARKINSONS-DISEASE

      Journal of neural transmission
    70. LAIHINEN AO; RINNE JO; NAGREN KA; LEHIKOINEN PK; OIKONEN VJ; RUOTSALAINEN UH; RUOTTINEN HM; RINNE UK
      PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    71. RINNE JO; HUBLIN C; PARTINEN M; RUOTTINEN H; RUOTSALAINEN U; NAGREN K; LEHIKOINEN P; LAIHINEN A
      POSITRON EMISSION TOMOGRAPHY STUDY OF HUMAN NARCOLEPSY - NO INCREASE IN STRIATAL DOPAMINE D-2 RECEPTORS

      Neurology
    72. RINNE JO; KUIKKA J; LAIHINEN A; NAGREN K; LEHIKOINEN P; BERGSTROM K; RUOTSALAINEN U; RUOTTINEN H; RINNE UK
      A COMPARISON OF [I-123] BETA-CIT SPECT AND [C-11] BETA-CIT PET IN IMAGING THE MONOAMINE TRANSPORTERS IN PARKINSONS-DISEASE

      Neurology
    73. LAIHINEN A; RINNE JO; RUOTTINEN H; NAGREN K; LEHIKOINEN P; OIKONEN V; RUOTSALAINEN U; RINNE UK
      DOPAMINE D1 RECEPTORS IN NORMAL AND PARKINSONIAN BRAINS STUDIED WITH [C-11] SCH 39166 AND [C-11] NNC 756

      Neurology
    74. RINNE JO; LAIHINEN A; RUOTTINEN H; RUOTSALAINEN U; NAGREN K; LEHIKOINEN P; OIKONEN V; RINNE UK
      INCREASED DENSITY OF DOPAMINE D2 RECEPTORS IN THE PUTAMEN, BUT NOT INTHE CAUDATE-NUCLEUS IN EARLY PARKINSONS-DISEASE - A PET STUDY WITH [C-11] RACLOPRIDE

      Journal of the neurological sciences
    75. LAMUSUO S; FORSS N; HAAPARANTA M; HARI R; MERVAALA E; MAKELA JP; RINNE JO; RUOTSALAINEN U; VALPALAHTI M
      FDG-PET AND WHOLE-SCALP MAGNETOENCEPHALOGRAPHY IN THE LOCALIZATION OFEPILEPTOGENIC CORTEX

      Epilepsia
    76. BURN DJ; RINNE JO; QUINN NP; LEES AJ; MARSDEN CD; BROOKS DJ
      STRIATAL OPIOID RECEPTOR-BINDING IN PARKINSONS-DISEASE, STRIATONIGRALDEGENERATION AND STEELE-RICHARDSON-OLSZEWSKI SYNDROME - A [C-11] DIPRENORPHINE PET STUDY

      Brain
    77. RINNE JO; DANIEL SE; SCARAVILLI F; PIRES M; HARDING AE; MARSDEN CD
      THE NEUROPATHOLOGICAL FEATURES OF NEUROACANTHOCYTOSIS

      Movement disorders
    78. SALONEN R; RINNE JO; HALONEN P; PUUSA A; MARTTILA R; VILJANEN MK
      LYME BORRELIOSIS ASSOCIATED WITH COMPLETE FLACCID PARAPLEGIA

      The Journal of infection
    79. LAIHINEN AO; RINNE JO; RUOTTINEN HM; NAGREN KA; LEHIKOINEN PK; OIKONEN VJ; RUOTSALAINEN UH; RINNE UK
      PET STUDIES ON DOPAMINE D1 RECEPTORS IN THE HUMAN BRAIN WITH CARBON-11-SCH-39166 AND CARBON-11-NNC-756

      The Journal of nuclear medicine
    80. RINNE JO; DANIEL SE; SCARAVILLI F; HARDING AE; MARSDEN CD
      NIGRAL DEGENERATION IN NEUROACANTHOCYTOSIS

      Neurology
    81. LEE MS; RINNE JO; CEBALLOSBAUMANN A; THOMPSON PD; MARSDEN CD
      DYSTONIA AFTER HEAD TRAUMA

      Neurology
    82. RINNE JO; LEE MS; THOMPSON PD; MARSDEN CD
      CORTICOBASAL DEGENERATION - A CLINICAL-STUDY OF 36 CASES

      Brain
    83. RINNE JO
      NIGRAL DEGENERATION IN PARKINSONS-DISEASE

      Movement disorders
    84. RINNE JO; LONNBERG P; MARJAMAKI P; MOLSA P; SAKO E; PALJARVI L
      BRAIN METHIONINE-ENKEPHALIN AND LEUCINE-ENKEPHALIN RECEPTORS IN PATIENTS WITH DEMENTIA

      Neuroscience letters
    85. PAIVARINTA MA; MARTTILA RJ; RINNE JO; RINNE UK
      DOPAMINERGIC NEUROTRANSMISSION IN CHRONIC HERPES-SIMPLEX VIRUS BRAIN INFECTION IN RABBITS

      Journal of neural transmission
    86. RINNE JO; LONNBERG P; MARJAMAKI P
      HUMAN BRAIN METHIONINE-ENKEPHALINS AND LEUCINE-ENKEPHALINS AND THEIR RECEPTORS DURING AGING

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 14:45:04